gdc
PSSGuide_2021

Cervical Cancer

Cervical CancerSlideshows
About 12,900 women are diagnosed with cervical cancer each year in the United States, this fact and more in our slideshow on cervical cancer.
Cervical CancerPatient Stories
Read Erica Stum's thoughtful exploration of faith in relation to a cancer diagnosis.
Cervical CancerHPV Infection & Cancer
Cervical cancer is among the 3 most common types of gynecologic cancers, along with ovarian and endometrial cancers. There are currently 3 approved vaccines that differ in the HPV types that they target for the prevention of HPV infection and cervical cancer.
Cancer ScreeningCervical CancerGynecologic CancersOvarian Cancer
Dr. Julian Schink, GYN Oncology Chief of Cancer Treatment Centers of America, provides screening tips and recommendations for these 2 most common gynecologic cancers.
Cervical CancerPatient Stories
Read Erica Stum's thoughtful exploration of faith in relation to a cancer diagnosis.
Cervical CancerPatient Stories
Jacky Costello details how her cancer journey has scarred her but ultimately made her stronger, which taught her valuable lessons about seeking support from others and finding strength through change.
HPV Infection & CancerSexuality & CancerCervical Cancer
HPV infection is the most common sexually transmitted disease and the cause of several types of cancer, including anal cancer. Several experts explain the effectiveness of the HPV vaccine in preventing these cancers, something that we should all be aware of.
Cervical Cancer
This article explains why for women with advanced cervical cancer, using adjuvant chemotherapy has no benefit, and possible severe side effects.
FDA Approvals, News & UpdatesCervical Cancer
In September, the FDA approved Tivdak (tisotumab vedotin) for the treatment of women with recurrent or metastatic cervical cancer that progressed during or after chemotherapy. This is the first tissue factor–directed antibody and microtubule inhibitor conjugate approved for women with advanced cervical cancer.
FDA Approvals, News & UpdatesCervical Cancer
In October 2021, the FDA approved the immunotherapy Keytruda (pembrolizumab), in combination with chemotherapy and with or without Avastin (bevacizumab), for patients with persistent, recurrent, or metastatic cervical cancer and PD-L1 expression.
Cervical Cancer
Cervical cancer during pregnancy can be successfully managed with a multidisciplinary treatment team and an individualized treatment strategy that optimizes maternal treatment while considering fetal safety.
Cervical Cancer
Find financial assistance programs available for cervical cancer drugs.

Results 1 - 13 of 13

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link

Subscribe to CONQUER: the patient voice

Receive timely cancer news & updates, patient stories, and more.


Country
Race or Ethnicity
Gender
Profession or Role
Primary Interest